Quadrant Capital Group LLC Amneal Pharmaceuticals, Inc. Transaction History

Quadrant Capital Group LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$1.27 - $2.7 $2,722 - $5,788	-2,144 Reduced 86.73%	328 $0
Q4 2022 Feb 10, 2023	BUY	$1.96 - $2.61 $3,382 - $4,504	1,726 Added 231.37%	2,472 $4,000
Q3 2022 Nov 10, 2022	BUY	$2.02 - $3.62 $1,506 - $2,700	746 New	746 $2,000
Q3 2019 Oct 24, 2019	SELL	$2.29 - $7.1 $272 - $844	-119 Closed	0 $0
Q1 2019 Apr 29, 2019	SELL	$11.87 - $14.84 $284 - $356	-24 Reduced 16.78%	119 $1,000
Q4 2018 Jan 17, 2019	SELL	$13.09 - $21.49 $602 - $988	-46 Reduced 24.34%	143 $1,000
Q2 2018 Aug 09, 2018	BUY	$13.95 - $20.2 $2,636 - $3,817	189 New	189 $2,000

185

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.26B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

Stay updated on Quadrant Capital Group LLC with notifications on news.